This inventor holds 2 USPTO granted patents. Top assignee: Yuhan Corporation. Active years: 2002-2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Kyunggi-do, KR (2002)
- Kyonggi-do, KR (2003)
Company Filing History:
Years Active: 2002-2003
Title: Seung Kyu Lee: Innovator in Pyrimidine Derivatives
Introduction
Seung Kyu Lee is a prominent inventor based in Kyunggi-do, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly through his work on pyrimidine derivatives. With a total of 2 patents, his innovations are paving the way for advancements in medical treatments.
Latest Patents
Seung Kyu Lee's latest patents focus on novel pyrimidine derivatives and their preparation processes. The first patent describes pyrimidine derivatives and pharmaceutically acceptable non-toxic salts that exhibit excellent inhibitory activity against gastric acid secretion. This invention also includes a pharmaceutical composition containing these derivatives as an active ingredient. The second patent similarly relates to pyrimidine derivatives that possess anti-secretory activity, along with their novel intermediates and preparation processes.
Career Highlights
Seung Kyu Lee is currently associated with Yuhan Corporation, a leading pharmaceutical company in South Korea. His work at Yuhan Corporation has allowed him to focus on innovative research and development in the pharmaceutical sector.
Collaborations
Throughout his career, Seung Kyu Lee has collaborated with notable colleagues, including Jong Wook Lee and Bong Yong Lee. These collaborations have contributed to the advancement of research in their respective fields.
Conclusion
Seung Kyu Lee's contributions to the field of pharmaceuticals through his innovative work on pyrimidine derivatives highlight his role as a significant inventor. His patents are expected to have a lasting impact on medical treatments and pharmaceutical development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
